BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8923568)

  • 1. Mecamylamine does not precipitate withdrawal in cigarette smokers.
    Eissenberg T; Griffiths RR; Stitzer ML
    Psychopharmacology (Berl); 1996 Oct; 127(4):328-36. PubMed ID: 8923568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute effects of nicotine and mecamylamine on tobacco withdrawal symptoms, cigarette reward and ad lib smoking.
    Rose JE; Behm FM; Westman EC
    Pharmacol Biochem Behav; 2001 Feb; 68(2):187-97. PubMed ID: 11267622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the nicotinic receptor antagonist mecamylamine on ad-lib smoking behavior, topography, and nicotine levels in smokers with and without schizophrenia: a preliminary study.
    McKee SA; Weinberger AH; Harrison EL; Coppola S; George TP
    Schizophr Res; 2009 Dec; 115(2-3):317-24. PubMed ID: 19700263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone.
    Rose JE; Behm FM; Westman EC; Levin ED; Stein RM; Ripka GV
    Clin Pharmacol Ther; 1994 Jul; 56(1):86-99. PubMed ID: 8033499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet monoamine oxidase, smoking cessation, and tobacco withdrawal symptoms.
    Rose JE; Behm FM; Ramsey C; Ritchie JC
    Nicotine Tob Res; 2001 Nov; 3(4):383-90. PubMed ID: 11694206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of acute abstinence, reinstatement, and mecamylamine on biochemical and behavioral measures of cigarette smoking in schizophrenia.
    Weinberger AH; Sacco KA; Creeden CL; Vessicchio JC; Jatlow PI; George TP
    Schizophr Res; 2007 Mar; 91(1-3):217-25. PubMed ID: 17293085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smokers deprived of cigarettes for 72 h: effect of nicotine patches on craving and withdrawal.
    Teneggi V; Tiffany ST; Squassante L; Milleri S; Ziviani L; Bye A
    Psychopharmacology (Berl); 2002 Nov; 164(2):177-87. PubMed ID: 12404080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mecamylamine moderates cue-induced emotional responses in smokers.
    McClernon FJ; Rose JE
    Addict Behav; 2005 May; 30(4):741-53. PubMed ID: 15833578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mecamylamine acutely increases human intravenous nicotine self-administration.
    Rose JE; Behm FM; Westman EC; Bates JE
    Pharmacol Biochem Behav; 2003 Sep; 76(2):307-13. PubMed ID: 14592683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mecamylamine treatment for alcohol dependence: a randomized controlled trial.
    Petrakis IL; Ralevski E; Gueorguieva R; O'Malley SS; Arias A; Sevarino KA; Jane JS; O'Brien E; Krystal JH
    Addiction; 2018 Jan; 113(1):6-14. PubMed ID: 28710873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotine-containing versus de-nicotinized cigarettes: effects on craving and withdrawal.
    Gross J; Lee J; Stitzer ML
    Pharmacol Biochem Behav; 1997; 57(1-2):159-65. PubMed ID: 9164567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New medications for nicotine dependence treatment.
    Hurt RD
    Nicotine Tob Res; 1999; 1 Suppl 2():S175-9; discussion S207-10. PubMed ID: 11768177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of mecamylamine on human cigarette smoking and subjective ratings.
    Nemeth-Coslett R; Henningfield JE; O'Keeffe MK; Griffiths RR
    Psychopharmacology (Berl); 1986; 88(4):420-5. PubMed ID: 3085131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotine patches and the subjective effects of cigarette smoking: a pilot study.
    Cárdenas L; Busto UE; MacDonald A; Corrigall WA
    Can J Clin Pharmacol; 2002; 9(4):175-82. PubMed ID: 12584575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Shiffman S
    Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of topiramate on cue-induced cigarette craving and the response to a smoked cigarette in briefly abstinent smokers.
    Reid MS; Palamar J; Raghavan S; Flammino F
    Psychopharmacology (Berl); 2007 May; 192(1):147-58. PubMed ID: 17345064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mecamylamine (Inversine): an old antihypertensive with new research directions.
    Shytle RD; Penny E; Silver AA; Goldman J; Sanberg PR
    J Hum Hypertens; 2002 Jul; 16(7):453-7. PubMed ID: 12080428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of opioidergic system on mecamylamine-precipitated nicotine-withdrawal aversion in rats.
    Ise Y; Narita M; Nagase H; Suzuki T
    Psychopharmacology (Berl); 2000 Jul; 151(1):49-54. PubMed ID: 10958116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A nicotine antagonist, mecamylamine, reduces cue-induced cocaine craving in cocaine-dependent subjects.
    Reid MS; Mickalian JD; Delucchi KL; Berger SP
    Neuropsychopharmacology; 1999 Mar; 20(3):297-307. PubMed ID: 10063490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical evaluation of mecamylamine for withdrawal from nicotine dependence.
    Tennant FS; Tarver AL; Rawson RA
    NIDA Res Monogr; 1984 Mar; 49():239-46. PubMed ID: 6434966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.